혈관 접근 장치 : 시장 인사이트, 경쟁 구도, 시장 예측(-2032년)

Vascular Access Device Market Summary

• The global vascular access device market is expected to increase from USD 5,450.01 million in 2024 to USD 8,413.65 million by 2032, reflecting strong and sustained growth.
• The global vascular access device market is growing at a CAGR of 6.40% during the forecast period from 2025 to 2032.
• The global vascular access device market is growing rapidly due to the rising prevalence of chronic diseases like cancer, kidney disorders, and cardiovascular conditions, which require long-term intravenous therapies. Advancements in device technology, including antimicrobial coatings and safety-engineered designs, have improved safety and usability, driving adoption. Increased use in chemotherapy, dialysis, and parenteral nutrition, along with the expanding geriatric population, further fuels demand for reliable vascular access solutions worldwide.
• The leading companies operating in the vascular access device market include Cook, BD, Teleflex Incorporated, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, Argon Medical Devices, and others.
• North America holds the highest share in the vascular access device market, driven by a well-established healthcare infrastructure, high prevalence of chronic diseases such as cardiovascular conditions, cancer, and chronic kidney disease, and an aging population. The region's strong adoption of advanced medical technologies, including smart and antimicrobial-coated catheters, further reinforces its market dominance globally.
• Within the central vascular access devices segment of the vascular access device market, the peripherally inserted central catheters category is projected to hold the largest share in 2024.

Factors Contributing to the Growth of the Vascular Access Device Market

• Increasing prevalence of chronic diseases leading to a surge in the vascular access device market: The rising incidence of chronic health conditions, including cancer, kidney disorders, and cardiovascular diseases, continues to be a major driver of the vascular access device market. Cancer cases, particularly those requiring chemotherapy, are increasing globally, necessitating long-term and reliable vascular access for repeated drug administration. Similarly, kidney disorders such as chronic kidney disease and end-stage renal failure are driving demand for hemodialysis, which relies heavily on vascular access devices for efficient treatment. Cardiovascular diseases, including heart failure and coronary artery disease, further contribute to sustained usage of these devices for intravenous therapies and monitoring. Collectively, the growing burden of these chronic diseases highlights the essential role of Vascular Access Devices in enabling continuous treatment, improving patient outcomes, and supporting long-term healthcare management worldwide.
• Advancements in Device Technology: Technological innovations in vascular access devices are enhancing their safety, functionality, and ease of use. Developments such as antimicrobial coatings, bioresorbable materials, safety-engineered catheters, and image-guided insertion techniques reduce infection risks, improve patient outcomes, and simplify procedures for healthcare professionals. These advancements make VADs more reliable and attractive to healthcare providers, increasing their adoption across hospitals, outpatient settings, and home care, thereby driving market expansion.
• Growing utilization in chemotherapy, dialysis, and parenteral nutrition: Vascular access devices are indispensable in treatments that require repeated or long-term intravenous access, such as chemotherapy, dialysis, and parenteral nutrition. The increasing incidence of cancer, renal disorders, and malnutrition-related conditions has led to higher demand for these therapies. As a result, healthcare facilities are increasingly investing in VADs to ensure the continuous and safe delivery of these treatments, directly boosting the market for these devices.

Vascular Access Device Market Report Segmentation

This vascular access device market report offers a comprehensive overview of the global vascular access device market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Device Type (Central Vascular Access Devices [Peripherally Inserted Central Catheters, Non-Tunneled Catheters, and Others] and Peripheral Vascular Access Devices [Peripheral Catheter, Midline Catheter (Short) Devices, and Others]), Route of Insertion (Intravenous and Subcutaneous), End-Users (Hospitals, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing vascular access device market.

Vascular access devices (VADs) are medical tools designed to provide reliable entry into a patient's vascular system for the delivery of fluids, medications, blood products, or for blood sampling. They include a range of devices such as peripheral intravenous (IV) catheters, central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and implantable ports. Chosen based on treatment duration and clinical needs, VADs are critical in managing acute and chronic conditions, ensuring efficient therapy, and minimizing repeated needle insertions.

The vascular access device market is witnessing robust growth, driven by multiple interrelated factors. The rising prevalence of chronic health conditions, including cancer, kidney disorders, and cardiovascular diseases, has significantly increased the need for reliable and long-term vascular access, as patients require frequent administration of medications, fluids, and blood products. Technological advancements in device design, such as antimicrobial coatings, safety-engineered catheters, bioresorbable materials, and image-guided insertion techniques, have further enhanced the safety, efficacy, and ease of use of these devices, encouraging wider adoption across healthcare settings.

Additionally, the growing utilization of vascular access devices in chemotherapy, dialysis, and parenteral nutrition reflects the critical need for sustained and efficient treatment delivery for patients with complex medical conditions. This demand is further amplified by the increasing geriatric population, which often requires repeated hospitalizations and long-term intravenous therapies, thereby reinforcing the essential role of vascular access devices in improving patient outcomes, enabling continuous care, and supporting the management of chronic and age-related health conditions worldwide.

What are the latest Vascular Access Device Market Dynamics and Trends?

The global vascular access device (VAD) market is witnessing significant growth, fueled by a confluence of factors including the rising prevalence of chronic diseases, technological innovations, and an increasing demand for long-term intravenous therapies. The escalating incidence of cancer, kidney disorders, and cardiovascular conditions remains a primary driver of market expansion.

According to DelveInsight analysis (2025), the number of new cancer cases is projected to reach approximately 21.5 million in 2025, with a substantial increase to 32.5 million by 2045. Prostate and colorectal cancers alone are expected to reach 2.65 million and 3.25 million cases, respectively, by 2045, underscoring the growing reliance on vascular access devices for chemotherapy administration and supportive treatments.

Cardiovascular diseases further contribute significantly to market demand, with approximately 60.05 million people globally suffering from atrial fibrillation (AF), a prevalent arrhythmia that dramatically increases the risk of stroke, heart failure, and blood clots. Coronary heart disease affects nearly 205 million individuals, while stroke prevalence remains high, with 56.5 million female and 45.5 million male survivors worldwide. Additionally, nearly 13.5 million people live with congenital heart disease, many of whom remain undiagnosed, creating an ongoing need for reliable vascular access solutions.

The rising burden of these chronic and life-threatening conditions necessitates safe, effective, and durable vascular access for therapies including chemotherapy, dialysis, and parenteral nutrition, thereby reinforcing market growth. Concurrently, advancements in device technology, such as antimicrobial coatings, safety-engineered designs, bioresorbable materials, AI integration, wireless connectivity, and miniaturization, are enhancing patient safety, improving clinical outcomes, and enabling smarter, remotely monitored solutions that cater to both hospital and home-care settings.

The expanding geriatric population, more prone to chronic illnesses and repeated hospitalizations, further fuels demand for vascular access devices. Growing awareness regarding early diagnosis and timely intervention, coupled with supportive regulatory frameworks in key markets, is accelerating adoption and driving market penetration.

Therefore, these factors underscore the critical role of vascular access devices in modern healthcare and position the market for substantial growth and sustained expansion over the coming years, reflecting a transformative shift toward advanced, patient-centric therapeutic solutions.

Despite strong growth prospects, the vascular access device market is constrained by several critical challenges. One of the foremost issues is the risk of catheter-related bloodstream infections, thrombosis, and other device-related complications, which not only compromise patient safety but also increase hospitalization durations and healthcare costs. Stringent regulatory requirements across key markets further delay product approvals and add to the financial and operational burden for manufacturers. High costs of advanced devices, including antimicrobial-coated and safety-engineered catheters, limit accessibility in developing countries where healthcare budgets are often constrained and reimbursement frameworks are less supportive. In addition, instances of device failures, recalls, and safety concerns can undermine patient and clinician confidence, posing reputational risks for manufacturers.

Collectively, these factors create significant barriers to widespread adoption, compelling companies to focus on innovations that enhance safety, improve reliability, and reduce costs to sustain growth in a highly regulated and safety-conscious market environment.

Vascular Access Device Market Segment Analysis

By Device Type (Central Vascular Access Devices [Peripherally Inserted Central Catheters, Non-Tunneled Catheters, and Others] and Peripheral Vascular Access Devices [Peripheral Catheter, Midline Catheter (Short) Devices, and Others]), Route of Insertion (Intravenous and Subcutaneous), End-Users (Hospitals, Ambulatory Surgical Centers and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

North America Vascular Access Device Market Trends

North America, led by the United States, dominates the global vascular access device market, accounting for approximately 49% of the total market share in 2024. The North American vascular access device market is witnessing robust growth, driven by a combination of factors including rising prevalence of chronic diseases such as cancer and kidney disease, and continuous technological advancements. A major factor propelling this expansion is the high prevalence of cardiovascular diseases, particularly coronary heart disease, which remains the most common form of heart disease in the region. Coupled with an aging population, this is intensifying demand for diagnostic, monitoring, and therapeutic interventions, further boosting the adoption of vascular access devices.

Cancer prevalence is another critical driver of market growth. In 2022, North America recorded over 2.38 million cancer cases, a figure projected to rise to nearly 2.8 million by 2030, with more than 2 million new cases expected in 2025 alone. Patients undergoing chemotherapy and other cancer treatments require reliable, long-term vascular access, directly increasing demand for both central and peripheral catheters.

Similarly, chronic kidney disease is a growing concern, affecting approximately 35.7 million adults, or around 14% of the U.S. population in 2024. The rising number of dialysis treatments necessitates repeated vascular access, further driving the adoption of specialized devices.

Technological innovations are amplifying these trends. Smart catheters with real-time monitoring capabilities, robotic-assisted insertion systems, and antimicrobial-coated devices are improving patient safety, reducing complications, and enhancing procedural efficiency. Hospitals, clinics, and outpatient care centers are increasingly investing in these advanced vascular access solutions to meet the needs of patients with chronic illnesses, cancer, and age-related conditions.

The convergence of these factors, rising chronic disease prevalence, an aging population, increasing cancer and kidney disease cases, and rapid technological innovation, is creating sustained demand for vascular access devices, positioning North America as a leading hub for the development and adoption of next-generation medical technologies.

Europe Vascular Access Device Market Trends

This growth is driven primarily by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which require repeated administration of medications and fluids through vascular access devices. The increasing number of chemotherapy treatments and growing use of these devices in pediatric patients further contribute to the market expansion.

Technological advancements in vascular access devices, such as antimicrobial-coated catheters and sensor-enabled technologies, are enhancing safety and reducing complications like infections and thrombosis. These innovations, coupled with increasing research activities and clinical trials in Europe, are accelerating adoption. The market is dominated by short peripheral intravenous catheters in terms of revenue, while midline catheters represent the fastest-growing product segment due to their clinical benefits.

Geographically, countries such as the UK, Germany, France, Spain, and Italy lead the market, with the UK expected to hold the largest share due to advanced healthcare infrastructure and significant R&D investments. Regulatory compliance with the EU Medical Device Regulation (MDR) and adoption of new therapeutic methods are also influencing market dynamics. Additionally, there's a noticeable shift toward home-infusion therapies and minimally invasive procedures, which further propel demand for advanced vascular access solutions in Europe.

Therefore, the market reflects a balance of steady demand growth, technological innovation, and evolving healthcare practices.

Asia-Pacific Vascular Access Device Market Trends

The Asia-Pacific vascular access device market is experiencing strong growth momentum, projected to register a robust CAGR from 2025 to 2032. The Asia-Pacific vascular access device market is growing rapidly and is projected to continue expanding significantly due to the rising prevalence of chronic diseases such as cancer, chronic kidney disease, cardiovascular conditions, diabetes, and lifestyle-related illnesses, which increase demand for vascular access therapies. The region's large and aging population further contributes to market expansion, as older adults require more frequent medical interventions. Countries like India, China, and Japan are key markets, with India expected to register the highest growth rate.

Short peripheral intravenous catheters are currently the largest product segment, while midline catheters are the fastest-growing due to their clinical advantages. Market growth is also fueled by increased healthcare infrastructure development, government support, and rising healthcare spending. Several regional and global companies actively invest in research and new product launches, accelerating technological advancements.

Additionally, increasing adoption of minimally invasive procedures and emphasis on infection control in vascular access procedures are shaping the market's upward trajectory. Overall, the Asia-Pacific region stands out as the fastest-growing market globally, driven by expanding patient populations, healthcare improvements, and continuous innovation in vascular access devices.

Who are the major players in the Vascular Access Device Market?

The following are the leading companies in the vascular access device market. These companies collectively hold the largest market share and dictate industry trends.

• Cook
• BD
• Teleflex Incorporated
• Medtronic
• Asahi Kasei Corporation
• B. Braun SE
• PRODiMED
• AMECATH
• Terumo Corporation
• AngioDynamics
• ICU Medical, Inc.
• Nipro Medical Corporation
• Medline Industries, LP
• Access Vascular, Inc.
• Vygon Group
• Cordis
• Merit Medical Systems
• Cardinal Health
• Fresenius SE & Co. KGaA
• Argon Medical Devices

How is the competitive landscape shaping the Vascular Access Device Market?

The competitive landscape of the vascular access device market reflects a balance between established global corporations and emerging innovators. The market remains moderately consolidated, with major players such as Medtronic, Becton Dickinson, Baxter International, and Smiths Medical commanding substantial market share, particularly in advanced central vascular access and high-tech device categories. These leaders maintain their dominance through continuous research and development, well-recognized brands, and diversified product portfolios that address multiple therapeutic areas and patient care needs.

At the same time, smaller, agile companies and startups are reshaping the market by introducing disruptive technologies and innovative solutions. Many of these new entrants are driving growth in fast-evolving segments, such as smart PICCs, AI-integrated monitoring devices, and minimally invasive insertion systems. By leveraging features like wireless connectivity, real-time monitoring, and patient-friendly designs, they are facilitating a shift from hospital-centric care to more flexible, outpatient, and home-based vascular access management.

This dynamic interplay between established incumbents and innovative disruptors is fostering a competitive environment characterized by rapid technological advancement and strategic alignment. Larger corporations are increasingly pursuing partnerships, collaborations, and acquisitions to integrate breakthrough technologies, enhance procedural efficiency, and maintain leadership in a rapidly evolving market. As a result, competition is not only expanding technological capabilities but also accelerating the adoption of safer, more efficient, and patient-centric vascular access solutions worldwide.

Recent Developmental Activities in the Vascular Access Device Market

• In September 2025, PatenSee, a clinical-stage medical device company, announced that the U.S. Food and Drug Administration (FDA) had awarded Breakthrough Device Designation to its non-contact vascular access management technology for patients receiving hemodialysis. This designation offers an expedited regulatory pathway, aimed at accelerating the development and adoption of PatenSee's platform within dialysis clinics.
• In September 2024, B. Braun Medical Inc., a leading provider of smart infusion therapy and pain management solutions, announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for its Introcan Safety(R) 2 Deep Access IV Catheter, the latest addition to the Introcan Safety 2 IV Catheter portfolio.
• In January 2022, ICU Medical Inc. announced the successful completion of its acquisition of Smiths Medical from Smiths Group plc. The Smiths Medical portfolio encompasses syringe and ambulatory infusion devices, vascular access products, and vital care solutions. The merger with ICU Medical's existing businesses establishes a leading global infusion therapy company, with estimated pro forma combined revenues of approximately $2.5 billion.

Vascular Access Device Market Segmentation

• Vascular Access Device Product Type Exposure
• Central Vascular Access Devices
• Peripherally Inserted Central Catheters
• Non-Tunneled Catheters
• Others
• Peripheral Vascular Access Devices
• Peripheral Catheter
• Midline Catheter (Short) Devices
• Others
• Vascular Access Device Route of Insertion Exposure
• Intravenous
• Subcutaneous
• Vascular Access Device End-Users Exposure
• Hospitals
• Ambulatory Surgical Centers
• Others
• Vascular Access Device Geography Exposure
• North America Vascular Access Devices Market
• United States Vascular Access Devices Market
• Canada Vascular Access Devices Market
• Mexico Vascular Access Devices Market
• Europe Vascular Access Devices Market
• United Kingdom Vascular Access Devices Market
• Germany Vascular Access Devices Market
• France Vascular Access Devices Market
• Italy Vascular Access Devices Market
• Spain Vascular Access Devices Market
• Rest of Europe Vascular Access Devices Market
• Asia-Pacific Vascular Access Devices Market
• China Vascular Access Devices Market
• Japan Vascular Access Devices Market
• India Vascular Access Devices Market
• Australia Vascular Access Devices Market
• South Korea Vascular Access Devices Market
• Rest of Asia-Pacific Vascular Access Devices Market
• Rest of the World Vascular Access Devices Market
• South America Vascular Access Devices Market
• Middle East Vascular Access Devices Market
• Africa Vascular Access Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered technologies are increasingly transforming the vascular access device market by enabling smarter, more efficient, and patient-centric solutions. Artificial intelligence is being integrated into vascular access systems to optimize device placement, predict complications, and provide real-time monitoring, significantly enhancing clinical outcomes. These innovations support early detection of catheter-related infections, thrombosis, and occlusions, reducing hospital readmissions and improving patient safety.

Additionally, AI-enabled devices facilitate remote monitoring and personalized therapy adjustments, allowing clinicians to tailor treatment protocols to individual patient needs. By streamlining procedural workflows, minimizing human error, and enhancing predictive analytics, AI-powered vascular access solutions are driving operational efficiency for healthcare providers.

Overall, the adoption of AI is expected to accelerate market growth by improving device performance, patient outcomes, and cost-effectiveness across acute care, outpatient, and home healthcare settings.

U.S. Tariff Impact Analysis on the Vascular Access Device Market:

The U.S. vascular access device market is moderately sensitive to tariff policies due to the significant volume of imported medical devices and raw materials used in manufacturing catheters, ports, and infusion systems. Increased tariffs on medical imports can raise production and procurement costs, which may be passed on to healthcare providers and patients, potentially impacting adoption rates, especially in cost-sensitive segments. Higher import duties could also influence global supply chains, prompting manufacturers to consider reshoring production or sourcing components domestically to mitigate cost pressures.

Conversely, tariff adjustments may create opportunities for domestic device manufacturers to expand market share by offering competitively priced alternatives. Overall, while the U.S. remains one of the largest markets for vascular access devices, tariff fluctuations introduce a degree of financial uncertainty that can affect pricing strategies, investment decisions, and overall market dynamics.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Vascular Access Device market report study

• Market size analysis for the current vascular access device market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the vascular access device market.
• Various opportunities available for the other competitors in the vascular access device market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current vascular access device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the vascular access device market growth in the future?

Frequently Asked Questions for the Vascular Access Device Market

1. What is the growth rate of the vascular access device market?

• The vascular access device market is estimated to grow at a CAGR of 6.40% during the forecast period from 2025 to 2032.

2. What is the market for vascular access devices?

• The vascular access device market was valued at USD 5,450.01 million in 2024 and is expected to reach USD 8,413.65 million by 2032.

3. Which region has the highest share in the Vascular Access Device market?

• North America holds the highest share in the vascular access device market, driven by a well-established healthcare infrastructure, high prevalence of chronic diseases such as cardiovascular conditions, cancer, and chronic kidney disease, and an aging population. The region's strong adoption of advanced medical technologies, including smart and antimicrobial-coated catheters, further reinforces its market dominance globally.

4. What are the drivers for the Vascular Access Device market?

• The global vascular access device market is growing rapidly due to the rising prevalence of chronic diseases like cancer, kidney disorders, and cardiovascular conditions, which require long-term intravenous therapies. Advancements in device technology, including antimicrobial coatings and safety-engineered designs, have improved safety and usability, driving adoption. Increased use in chemotherapy, dialysis, and parenteral nutrition, along with the expanding geriatric population, further fuels demand for reliable vascular access solutions worldwide.

5. Who are the key players operating in the Vascular Access Device market?

• Some of the key market players operating in the vascular access device market include Cook, BD, Teleflex Incorporated, Medtronic, Asahi Kasei Corporation, B. Braun SE, PRODiMED, AMECATH, Terumo Corporation, AngioDynamics, ICU Medical, Inc., Nipro Medical Corporation, Medline Industries, LP, Access Vascular, Inc., Vygon Group, Cordis, Merit Medical Systems, Cardinal Health, Fresenius SE & Co. KGaA, Argon Medical Devices, and Others.

Table of Contents

1. Vascular Access Device Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Vascular Access Device Market Executive Summary

• 2.1 Market at Glance

3. Vascular Access Device Market Key Factors Analysis

• 3.1 Vascular Access Device Market Drivers
  • 3.1.1 The increasing prevalence of chronic diseases
  • 3.1.2 Advancements in device technology
  • 3.1.3 Growing utilization in chemotherapy, dialysis, and parenteral nutrition
  • 3.1.4 Increasing geriatric population
• 3.2 Vascular Access Device Market Restraints and Challenges
  • 3.2.1 Risk of catheter-related infections
  • 3.2.2 Stringent regulatory approvals
• 3.3 Vascular Access Device Market Opportunity
  • 3.3.1 Rising adoption of home infusion therapies and outpatient care
  • 3.3.2 Growing focus on minimally invasive procedures

4. Impact Analysis

• 4.1 AI-Powered Innovations and Applications
• 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1 The United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Vascular Access Device Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Vascular Access Device Market Assessment

• 7.1 By Device Type
  • 7.1.1 Central Vascular Access Devices
    • 7.1.1.1 Peripherally Inserted Central Catheters
    • 7.1.1.2 Non-Tunneled Catheters
    • 7.1.1.3 Others
  • 7.1.2 Peripheral Vascular Access Devices
    • 7.1.2.1 Peripheral Catheter
    • 7.1.2.2 Midline Catheter (Short) Devices
    • 7.1.2.3 Others
• 7.2 By Route of Insertion
  • 7.2.1 Intravenous
  • 7.2.2 Subcutaneous
• 7.3 By End-Users
  • 7.3.1 Hospitals
  • 7.3.2 Ambulatory Surgical Centers
  • 7.3.3 Others
• 7.4 By Geography
  • 7.4.1 North America
    • 7.4.1.1 United States Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.1.2 Canada Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.1.3 Mexico Vascular Access Device Market Size in USD million (2022-2032)
  • 7.4.2 Europe
    • 7.4.2.1 France Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.2.2 Germany Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.2.3 United Kingdom Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.2.4 Italy Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.2.5 Spain Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.2.6 Rest of Europe Vascular Access Device Market Size in USD million (2022-2032)
  • 7.4.3 Asia-Pacific
    • 7.4.3.1 China Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.3.2 Japan Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.3.3 India Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.3.4 Australia Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.3.5 South Korea Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.3.6 Rest of Asia-Pacific Vascular Access Device Market Size in USD million (2022-2032)
  • 7.4.4 Rest of the World (RoW)
    • 7.4.4.1 Middle East Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.4.2 Africa Vascular Access Device Market Size in USD million (2022-2032)
    • 7.4.4.3 South America Vascular Access Device Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Vascular Access Device Market Company and Product Profiles

• 10.1 Cook
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Product Listing
  • 10.1.5 Entropy
• 10.2 BD
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Listing
  • 10.2.5 Entropy
• 10.3 Teleflex Incorporated
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Listing
  • 10.3.5 Entropy
• 10.4 Medtronic
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Listing
  • 10.4.5 Entropy
• 10.5 Asahi Kasei Corporation
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Listing
  • 10.5.5 Entropy
• 10.6 B. Braun SE,
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Listing
  • 10.6.5 Entropy
• 10.7 PRODiMED
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Listing
  • 10.7.5 Entropy
• 10.8 AMECATH
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Listing
  • 10.8.5 Entropy
• 10.9 Terumo Corporation
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Listing
  • 10.9.5 Entropy
• 10.10 AngioDynamics
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Listing
  • 10.10.5 Entropy
• 10.11 ICU Medical, Inc.
  • 10.11.1 Company Overview
  • 10.11.2 Company Snapshot
  • 10.11.3 Financial Overview
  • 10.11.4 Product Listing
  • 10.11.5 Entropy
• 10.12 Nipro Medical Corporation
  • 10.12.1 Company Overview
  • 10.12.2 Company Snapshot
  • 10.12.3 Financial Overview
  • 10.12.4 Product Listing
  • 10.12.5 Entropy
• 10.13 Medline Industries, LP
  • 10.13.1 Company Overview
  • 10.13.2 Company Snapshot
  • 10.13.3 Financial Overview
  • 10.13.4 Product Listing
  • 10.13.5 Entropy
• 10.14 Access Vascular, Inc
  • 10.14.1 Company Overview
  • 10.14.2 Company Snapshot
  • 10.14.3 Financial Overview
  • 10.14.4 Product Listing
  • 10.14.5 Entropy
• 10.15 Vygon Group
  • 10.15.1 Company Overview
  • 10.15.2 Company Snapshot
  • 10.15.3 Financial Overview
  • 10.15.4 Product Listing
  • 10.15.5 Entropy
• 10.16 Cordis
  • 10.16.1 Company Overview
  • 10.16.2 Company Snapshot
  • 10.16.3 Financial Overview
  • 10.16.4 Product Listing
  • 10.16.5 Entropy
• 10.17 Merit Medical Systems
  • 10.17.1 Company Overview
  • 10.17.2 Company Snapshot
  • 10.17.3 Financial Overview
  • 10.17.4 Product Listing
  • 10.17.5 Entropy
• 10.18 Cardinal Health,
  • 10.18.1 Company Overview
  • 10.18.2 Company Snapshot
  • 10.18.3 Financial Overview
  • 10.18.4 Product Listing
  • 10.18.5 Entropy
• 10.19 Fresenius SE & Co. KGaA
  • 10.19.1 Company Overview
  • 10.19.2 Company Snapshot
  • 10.19.3 Financial Overview
  • 10.19.4 Product Listing
  • 10.19.5 Entropy
• 10.20 Argon Medical Devices
  • 10.20.1 Company Overview
  • 10.20.2 Company Snapshot
  • 10.20.3 Financial Overview
  • 10.20.4 Product Listing
  • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us